Publicaciones científicas

Búsqueda avanzada

Mieloma múltiple y nuevos fármacos

Año: 2011
- Effects of Lenalidomide and Dexamethasone Treatment Duration on Survival in Patients With Relapsed or Refractory Multiple Myeloma Treated With Lenalidomide and Dexamethasone
  Jesús Fernando San Miguel Izquierdo; Meletios A. Dimopoulos; Edward A. Stadtmauer; S. Vincent Rajkumar; David Siegel; Marie-Laure Bravo; Marta Olesnyckyj; Robert D. Knight; Jerome B. Zeldis; Jean-Luc Harousseau; Donna M. Weber
  Clinical Lymphoma Myeloma & Leukemia 11: 38-43. FI: 1,988(Q3)
- Efficacy and Safety of Pegylated Liposomal Doxorubicin in Combination With Bortezomib for Multiple Myeloma: Effects of Adverse Prognostic Factors on Outcome
  Joan Blade; Pieter Sonneveld; Jesús Fernando San Miguel Izquierdo; Heather J. Sutherland; Roman Hajek; Arnon Nagler; Andrew Spencer; Tadeusz Robak; Keith C. Lantz; Sen H. Zhuang; Jean-Luc Harousseau; Robert Z. Orlowski; DOXIL-MMY-3001 Study Investigators
  Clinical Lymphoma Myeloma & Leukemia 11: 44-49. FI: 1,988(Q3)
- Emerging therapies for the treatment of relapsed or refractory multiple myeloma
  Meletios A. Dimopoulos; Jesús Fernando San Miguel Izquierdo; Kenneth C. Anderson
  European Journal Of Haematology 86: 1-15. FI: 2,785(Q2)
- Fewer bone disease events, improvement in bone remodeling, and evidence of bone healing with bortezomib plus melphalan-prednisone vs. melphalan-prednisone in the phase III VISTA trial in multiple myeloma
  Michel Delforge; Evangelos Terpos; Paul G. Richardson; Ofer Shpilberg; Nuriet K. Khuageva; Rudolf Schlag; Meletios A. Dimopoulos; Martin Kropff; Ivan Spicka; Maria T. Petrucci; Olga S. Samoilova; María Victoria Mateos ; Hila Magen-Nativ; Hartmut Goldschmidt; Dixie-Lee Esseltine; Deborah S. Ricci; Kevin Liu; William Deraedt; Andrew Cakana; Helgi van de Velde; Jesús Fernando San Miguel Izquierdo
  European Journal Of Haematology 86: 372-384. FI: 2,785(Q2)
- Frequency of HLA-A, -B and-DRB1 specificities and haplotypic associations in the population of Castilla y Leon (northwest-central Spain)
  Miguel Alcoceba ; Luis Alberto Marin Rubio; Ana Balanzategui Echevarria; MARIA EUGENIA ALONSO SARASQUETE; María del Carmen Chillón Santos; P. Martin-Jimenez; Noemí Puig Morón; C. Santamaria; ROCIO CORRAL MONFORTE; Ramón García Sanz ; Jesús Fernando San Miguel Izquierdo; M. Gonzalez
  Tissue Antigens 78: 249-255. FI: 3,024(Q1)
- Future Directions of Next-Generation Novel Therapies, Combination Approaches, and the Development of Personalized Medicine in Myeloma
  Constantine S. Mitsiades; Faith E. Davies; Jacob P. Laubach; Douglas Joshua; Jesús Fernando San Miguel Izquierdo; Kenneth C. Anderson; Paul G. Richardson
  Journal Of Clinical Oncology 29: 1916-1923. FI: 18,970(Q1)
- High-Risk Cytogenetics and Persistent Minimal Residual Disease (MRD) by Multiparameter Flow Cytometry (MFC) Predict Unsustained Complete Response (CR) After Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM)
  Bruno David Lourenço Paiva; Norma Carmen Gutiérrez Gutiérrez; Laura Rosinol; María Belén Vidriales Vicente; Maria-Angeles Montalban; Joaquin Martinez-Lopez; María Victoria Mateos ; Maria Teresa Cibeira; Lourdes Courdon; Albert Oriol; Maria Jose Terol; Maria-Asuncion Echebeste; Raquel de Paz; Felipe de Arriba; Luis Palomera; Javier De La Rubia; Joaquin Diaz-Mediavilla; Anna Sureda; Ana Gorosquieta; Adrian Alegre; Alejandro Martín García Sancho; Miguel T. Hernandez; Juan Jose Lahuerta; Joan Blade; Jesús Fernando San Miguel Izquierdo
  Blood 118: 287-288. FI: 10,558(Q1)
- Influence of Lenalidomide Treatment on Immune Effector Cells From High-Risk Smoldering Multiple Myeloma (SMM) Patients
  Bruno David Lourenço Paiva; María Victoria Mateos ; Lucía López Corral; María Belén Vidriales Vicente; Miguel T. Hernandez; Joan Bargay; Felipe de Arriba; Javier De la Rubia; Ana-Isabel Teruel; Pilar Giraldo; Laura Rosinol; Felipe Prosper; Albert Oriol; Jose Hernandez; Graca Esteves; Fernando Leal da Costa; Juan Jose Lahuerta; Joan Blade; Jesús Fernando San Miguel Izquierdo
  Blood 118: 1686-0. FI: 10,558(Q1)
- International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation
  Michele Cavo; S. Vincent Rajkumar; Antonio Palumbo; Philippe Moreau; Robert Orlowski; Joan Blade; Orhan Sezer; Heinz Ludwig; Meletios A. Dimopoulos; Michel Attal; Pieter Sonneveld; Mario Boccadoro; Kenneth C. Anderson; Paul G. Richardson; William Bensinger; Hans E. Johnsen; Nicolaus Kroeger; Gosta Gahrton; P. Leif Bergsagel; David H. Vesole; Hermann Einsele; Sundar Jagannath; Ruben Niesvizky; Brian G. M. Durie; Jesús Fernando San Miguel Izquierdo; Sagar Lonial; Int Myeloma Working Grp
  Blood 117: 6063-6073. FI: 10,558(Q1)
- Limbus Damage in Ocular Graft-versus-Host Disease
  Rebeca Lorenzo Perez; Jose A. Perez-Simon; Teresa Caballero-Velazquez; Teresa Flores Corral; María Soraya Carrancio Anton; M.Carmen Herrero Rodríguez; Belén Blanco Durango; Silvia Gutierrez-Cosio; Cristina Canete-Campos; Fernando Cruz Gonzalez; Jesús Fernando San Miguel Izquierdo; EMILIANO Hernández GALILEA; Ignacio Sanchez-Abarca
  Biology Of Blood And Marrow Transplantation 17: 270-273. FI: 3,275(Q2)

204 resultados

Páginas: << < 4 5 6 7 8 > >>

NoticiasNoticias
Zona del InvestigadorZona del Investigador